{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:42:00Z","timestamp":1778157720406,"version":"3.51.4"},"reference-count":200,"publisher":"Elsevier BV","issue":"9484","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/s0140-6736(05)67063-8","type":"journal-article","created":{"date-parts":[[2005,8,6]],"date-time":"2005-08-06T12:31:40Z","timestamp":1123331500000},"page":"491-505","source":"Crossref","is-referenced-by-count":1370,"title":["Endometrial cancer"],"prefix":"10.1016","volume":"366","author":[{"given":"Frederic","family":"Amant","sequence":"first","affiliation":[]},{"given":"Philippe","family":"Moerman","sequence":"additional","affiliation":[]},{"given":"Patrick","family":"Neven","sequence":"additional","affiliation":[]},{"given":"Dirk","family":"Timmerman","sequence":"additional","affiliation":[]},{"given":"Erik","family":"Van Limbergen","sequence":"additional","affiliation":[]},{"given":"Ignace","family":"Vergote","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(05)67063-8_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3322\/canjclin.49.1.33","article-title":"Global cancer statistics","volume":"49","author":"Parkin","year":"1999","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/S0140-6736(05)67063-8_bib2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0029-7844(96)00341-9","article-title":"Racial differences in endometrial cancer survival: the black\/white cancer survival study","volume":"88","author":"Hill","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib3","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.2105\/AJPH.94.12.2104","article-title":"Endometrial cancer: socioeconomic status and racial\/ethnic differences in stage at diagnosis, treatment, and survival","volume":"94","author":"Madison","year":"2004","journal-title":"Am J Public Health"},{"key":"10.1016\/S0140-6736(05)67063-8_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","article-title":"Cancer statistics 2005","volume":"55","author":"Jemal","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/S0140-6736(05)67063-8_bib6","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1038\/sj.bjc.6601763","article-title":"Effect of hysterectomy on incidence trends of endometrial and cervical cancer in Finland 1953\u20132010","volume":"90","author":"Luoto","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib7","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/jnci\/djh291","article-title":"Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands Cohort Study","volume":"96","author":"Schouten","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0140-6736(05)67063-8_bib8","author":"Van Eycken"},{"key":"10.1016\/S0140-6736(05)67063-8_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3322\/canjclin.53.1.27","article-title":"American Cancer Society guidelines for the early detection of cancer, 2003","volume":"53","author":"Smith","year":"2003","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/S0140-6736(05)67063-8_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00125480-200205000-00001","article-title":"Endometrioid carcinoma of the uterine corpus: a review of their pathology with emphasis on recent advances and problematic aspects","volume":"9","author":"Clement","year":"2002","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib11","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/00000478-199811000-00008","article-title":"Villoglandular adenocarcinoma of the endometrium: a clinicopathologic study of 61 cases","volume":"22","author":"Zaino","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib12","first-page":"154","article-title":"Squamous differentiation in carcinoma of the endometrium: a critical appraisal of adenoacanthoma and adenosquamous carcinoma","volume":"5","author":"Zaino","year":"1988","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib13","first-page":"125","article-title":"FIGO stage 1988 revision","volume":"35","author":"Creasman","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/1097-0142(19950101)75:1<81::AID-CNCR2820750114>3.0.CO;2-F","article-title":"The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system","volume":"75","author":"Zaino","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib15","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/00000478-200009000-00002","article-title":"A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advanced-stage tumors with favourable prognosis","volume":"24","author":"Lax","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib16","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2559.2004.01882.x","article-title":"Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type","volume":"44","author":"Stefansson","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/S0140-6736(05)67063-8_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00000478-198203000-00002","article-title":"Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma","volume":"6","author":"Hendrickson","year":"1982","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0090-8258(92)90130-B","article-title":"Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion and concomitant ovarian carcinoma","volume":"47","author":"Carcangiu","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ygyno.2003.08.018","article-title":"Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases","volume":"91","author":"Slomovitz","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib21","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/00000478-200006000-00004","article-title":"Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation","volume":"24","author":"Wheeler","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/1097-0142(19910701)68:1<98::AID-CNCR2820680120>3.0.CO;2-R","article-title":"Clear cell carcinoma of the endometrium: a histopathological and clinical study of 31 cases","volume":"68","author":"Abeler","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib23","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1097\/00000478-200412000-00004","article-title":"Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases","volume":"28","author":"Darvishian","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib24","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/0046-8177(95)90203-1","article-title":"Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation","volume":"26","author":"Ambros","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib25","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1097\/00000478-199712000-00015","article-title":"Stage IA uterine serous carcinoma: a study of 13 cases","volume":"21","author":"Carcangiu","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib26","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/00000478-200005000-00012","article-title":"Endometrial intraepithelial carcinoma with associated peritoneal carcinomatosis","volume":"24","author":"Soslow","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/1097-0142(19820701)50:1<163::AID-CNCR2820500131>3.0.CO;2-K","article-title":"Simultaneous presentation of carcinoma involving the ovary and the uterine corpus","volume":"50","author":"Eifel","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib28","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0046-8177(85)80210-0","article-title":"Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases","volume":"16","author":"Ulbright","year":"1985","journal-title":"Hum Pathol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib29","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/jnci\/djh272","article-title":"A molecular genetic and statistical approach for the diagnosis of dual-site cancers","volume":"96","author":"Brinkmann","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0140-6736(05)67063-8_bib30","series-title":"Blaustein's pathology of the female genital tract","first-page":"501","article-title":"Endometrial carcinoma","author":"Ronnett","year":"2002"},{"key":"10.1016\/S0140-6736(05)67063-8_bib31","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/jnci\/92.11.924","article-title":"Altered PTEN expression as a diagnostic marker for the earliest endometrial precancer","volume":"92","author":"Mutter","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0140-6736(05)67063-8_bib32","first-page":"2334","article-title":"Changes in endometrial PTEN expression throughout the human menstrual cycle","volume":"85","author":"Mutter","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0140-6736(05)67063-8_bib33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.2001.6352","article-title":"Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation","volume":"83","author":"Mutter","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib34","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ygyno.2003.11.026","article-title":"Involution of PTEN-null endometrial glands with progestin therapy","volume":"92","author":"Zheng","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib35","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/(SICI)1097-0142(19970115)79:2<320::AID-CNCR15>3.0.CO;2-2","article-title":"Progestin alone as primary treatment of endometrial carcinoma in premenopausal women: report of seven cases and review of the literature","volume":"79","author":"Kim","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/ng1097-143","article-title":"PTEN1 is frequently mutated in primary endometrial carcinomas","volume":"17","author":"Kong","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/S0140-6736(05)67063-8_bib37","first-page":"4736","article-title":"PTEN\/MMAC1 mutations in endometrial cancers","volume":"57","author":"Risinger","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/S0140-6736(05)67063-8_bib38","first-page":"5697","article-title":"Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas","volume":"63","author":"Moreno-Bueno","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/S0140-6736(05)67063-8_bib39","first-page":"5308","article-title":"K-ras activation in premalignant and malignant epithelial lesions of the human uterus","volume":"51","author":"Enomoto","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/S0140-6736(05)67063-8_bib40","first-page":"5632","article-title":"Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus","volume":"51","author":"Okamoto","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/S0140-6736(05)67063-8_bib41","first-page":"6","article-title":"Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer","volume":"63","author":"Risinger","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/S0140-6736(05)67063-8_bib42","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<814::AID-CNCR12>3.0.CO;2-U","article-title":"The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma","volume":"88","author":"Lax","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib43","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0090-8258(02)00094-X","article-title":"HER2\/neu overexpression: has the Achilles' heel of uterine serous papillary carcinoma been exposed?","volume":"88","author":"Santin","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib44","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1054\/bjoc.2000.1238","article-title":"Gene expression profiles of human endometrial cancer samples using a cDNA-expression array technique: assessment of an analysis method","volume":"83","author":"Smid-Koopman","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib45","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ijc.2910150411","article-title":"Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices","volume":"15","author":"Armstrong","year":"1975","journal-title":"Int J Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib46","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/jnci\/88.16.1127","article-title":"Case-control study of endogenous steroid hormones and endometrial cancer","volume":"88","author":"Potischman","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0140-6736(05)67063-8_bib47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0002-9378(00)70486-8","article-title":"Risk factors among young women with endometrial cancer: a Danish case-control study","volume":"182","author":"Parslov","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib48","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1054\/bjoc.2001.1704","article-title":"Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study","volume":"84","author":"Zeleniuch-Jacquotte","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib49","first-page":"1531","article-title":"Obesity, endogenous hormones and endometrial cancer risk: a synthetic review","volume":"11","author":"Kaaks","year":"2002","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/S0140-6736(05)67063-8_bib50","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(05)67063-8_bib51","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0378-5122(95)00935-E","article-title":"Insulin-like growth factor-binding protein-1: a biochemical marker of endometrial response to progestin during hormone replacement therapy","volume":"22","author":"Suvanto-Luukkonen","year":"1995","journal-title":"Maturitas"},{"key":"10.1016\/S0140-6736(05)67063-8_bib52","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1507\/endocrj.44.419","article-title":"Increased circulating levels of insulin-like growth factor-I and decreased circulating levels of insulin-like growth factor binding protein-1 in postmenopausal women with endometrial cancer","volume":"44","author":"Ayabe","year":"1997","journal-title":"Endocr J"},{"key":"10.1016\/S0140-6736(05)67063-8_bib53","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1073\/pnas.96.6.3287","article-title":"Insulin-like growth factor 1 is required for G2 progression in the estradiol-induced mitotic cycle","volume":"96","author":"Adesanya","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0140-6736(05)67063-8_bib54","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1158\/1055-9965.607.13.4","article-title":"Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a US case-control study","volume":"13","author":"Lacey","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S0140-6736(05)67063-8_bib55","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jsgi.2004.08.003","article-title":"Steroid-modulated proliferation of human endometrial carcinoma cell lines: any role for insulin-like growth factor signaling?","volume":"12","author":"Gielen","year":"2005","journal-title":"J Soc Gynecol Investig"},{"key":"10.1016\/S0140-6736(05)67063-8_bib56","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1023\/A:1008946825313","article-title":"Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden)","volume":"11","author":"Weiderpass","year":"2000","journal-title":"Cancer Causes Control"},{"key":"10.1016\/S0140-6736(05)67063-8_bib57","first-page":"611","article-title":"Diabetes and endometrial cancer in the Iowa women's health study","volume":"10","author":"Anderson","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S0140-6736(05)67063-8_bib58","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ijc.10974","article-title":"Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort","volume":"104","author":"Furberg","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib59","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1023\/A:1024866827775","article-title":"Physical activity and risk of endometrial cancer in a prospective cohort study (United States)","volume":"14","author":"Colbert","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1016\/S0140-6736(05)67063-8_bib60","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/S0140-6736(03)13409-5","article-title":"Polycystic ovary syndrome and endometrial carcinoma","volume":"361","author":"Hardiman","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(05)67063-8_bib61","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1158\/0008-5472.CAN-03-3393","article-title":"Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial","volume":"64","author":"McTiernan","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/S0140-6736(05)67063-8_bib62","first-page":"3955","article-title":"A polymorphism in CYP17 and endometrial cancer risk","volume":"61","author":"Haiman","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/S0140-6736(05)67063-8_bib63","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/oxfordjournals.aje.a009270","article-title":"Association of soy and fiber consumption with the risk of endometrial cancer","volume":"146","author":"Goodman","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib64","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/jnci\/djg015","article-title":"Phytoestrogen intake and endometrial cancer risk","volume":"95","author":"Horn-Ross","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0140-6736(05)67063-8_bib65","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/bmj.38093.646215.AE","article-title":"Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: population based case-control study","volume":"328","author":"Xu","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/S0140-6736(05)67063-8_bib66","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.fertnstert.2003.11.041","article-title":"Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study","volume":"82","author":"Unfer","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/S0140-6736(05)67063-8_bib67","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJM198509053131001","article-title":"Cigarette smoking and the risk of endometrial cancer","volume":"313","author":"Lesko","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(05)67063-8_bib68","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/ijc.20821","article-title":"Smoking and the risk of endometrial cancer: results from the Nurses' Health Study","volume":"114","author":"Viswanathan","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib69","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1001\/jama.1996.03540210055034","article-title":"Effects of alcohol ingestion on estrogens in postmenopausal women","volume":"276","author":"Ginsburg","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(05)67063-8_bib70","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1207\/S15327914NC4501_3","article-title":"Alcohol consumption and endometrial cancer: some unresolved issues","volume":"45","author":"Bandera","year":"2003","journal-title":"Nutr Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib71","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/ijc.10267","article-title":"Grand multiparity and incidence of endometrial cancer: a population-based study in Finland","volume":"98","author":"Hinkula","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib72","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1158\/1055-9965.1296.13.8","article-title":"Associations between reproductive and menstrual factors and postmenopausal sex hormone concentrations","volume":"13","author":"Chubak","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S0140-6736(05)67063-8_bib73","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1023\/A:1008921211309","article-title":"Cancer risk associated with subfertility and ovulation induction: a review","volume":"11","author":"Klip","year":"2000","journal-title":"Cancer Causes Control"},{"key":"10.1016\/S0140-6736(05)67063-8_bib74","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00006254-200202000-00024","article-title":"Noncontraceptive health benefits of intrauterine devices: a systematic review","volume":"57","author":"Hubacher","year":"2002","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/S0140-6736(05)67063-8_bib75","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/ije\/dyh046","article-title":"Tubal sterilization and risk of ovarian, endometrial and cervical cancer: a Danish population-based follow-up study of more than 65\u2008000 sterilized women","volume":"33","author":"Kjaer","year":"2004","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib76","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1196\/annals.1290.023","article-title":"Oral contraceptives and reproductive system cancer","volume":"997","author":"Deligeoroglou","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/S0140-6736(05)67063-8_bib77","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0378-5122(02)00031-2","article-title":"Endometrial safety of hormone replacement therapy: review of literature","volume":"42","author":"Van Gorp","year":"2002","journal-title":"Maturitas"},{"key":"10.1016\/S0140-6736(05)67063-8_bib78","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1001\/jama.290.13.1739","article-title":"Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial","volume":"290","author":"Anderson","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(05)67063-8_bib79","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(05)66455-0","article-title":"Endometrial cancer and hormone-replacement therapy in the Million Women Study","volume":"365","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(05)67063-8_bib80","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2165\/00002018-200528030-00005","article-title":"Tibolone and endometrial cancer: a cohort and nested case-control study in the UK","volume":"28","author":"de Vries","year":"2005","journal-title":"Drug Saf"},{"key":"10.1016\/S0140-6736(05)67063-8_bib81","first-page":"99","article-title":"Second cancer following cancer of the breast in Connecticut, 1935\u201382","volume":"68","author":"Harvey","year":"1985","journal-title":"Natl Cancer Inst Monogr"},{"key":"10.1016\/S0140-6736(05)67063-8_bib82","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ygyno.2004.04.009","article-title":"Association between uterine serous carcinoma and breast cancer","volume":"94","author":"Gehrig","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib83","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0140-6736(05)78091-0","article-title":"Longitudinal hysteroscopic follow-up during tamoxifen treatment","volume":"351","author":"Neven","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(05)67063-8_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002018-200022010-00001","article-title":"Guidelines for monitoring patients taking tamoxifen treatment","volume":"22","author":"Neven","year":"2000","journal-title":"Drug Saf"},{"key":"10.1016\/S0140-6736(05)67063-8_bib85","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0140-6736(03)12342-2","article-title":"Overview of the main outcomes in breast-cancer prevention trials","volume":"361","author":"Cuzick","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(05)67063-8_bib86","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01.AOG.0000131620.67911.03","article-title":"Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?","volume":"104","author":"Slomovitz","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib87","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1093\/jnci\/91.19.1654","article-title":"Tamoxifen therapy for breast cancer and endometrial cancer risk","volume":"91","author":"Bernstein","year":"1999","journal-title":"J Natl Cancer Inst"},{"issue":"suppl 4","key":"10.1016\/S0140-6736(05)67063-8_bib88","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0959-8049(00)00217-3","article-title":"Identification of women at high risk of developing endometrial cancer on tamoxifen","volume":"36","author":"Berliere","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib89","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ygyno.2004.03.048","article-title":"Endometrial pathologies associated with postmenopausal tamoxifen treatment","volume":"94","author":"Cohen","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib90","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1126\/science.1068537","article-title":"Molecular determinants for the tissue specificity of SERMs","volume":"295","author":"Shang","year":"2002","journal-title":"Science"},{"key":"10.1016\/S0140-6736(05)67063-8_bib91","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(00)03204-9","article-title":"Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: a randomised controlled trial","volume":"356","author":"Gardner","year":"2000","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1016\/S0140-6736(05)67063-8_bib92","article-title":"Intergroup Exemestane Study: results of the endometrial sub-protocol","volume":"88","author":"Bertelli","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/S0140-6736(05)67063-8_bib93","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/annonc\/mdi021","article-title":"Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients","volume":"16","author":"Morales","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib94","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/01.GME.0000058772.59606.2A","article-title":"Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years","volume":"10","author":"Jolly","year":"2003","journal-title":"Menopause"},{"key":"10.1016\/S0140-6736(05)67063-8_bib95","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0029-7844(03)00234-5","article-title":"Development of endometrial cancer after radiation treatment for cervical carcinoma","volume":"101","author":"Pothuri","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib96","first-page":"411","article-title":"A population-based study of endometrial cancer and familial risk in younger women","volume":"5","author":"Gruber","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S0140-6736(05)67063-8_bib97","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0959-8049(03)00627-0","article-title":"Familial clustering of ovarian and endometrial cancers","volume":"40","author":"Hemminki","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib98","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archinte.1966.03870080050009","article-title":"Hereditary factors in cancer","volume":"117","author":"Lynch","year":"1966","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0140-6736(05)67063-8_bib99","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc1278","article-title":"Testing guidelines for hereditary non-polyposis colorectal cancer","volume":"4","author":"Umar","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib100","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0959-8049(00)00356-7","article-title":"Ultrasonographic detection of asymptomatic endometrial cancer in postmenopausal patients offers no prognostic advantage over symptomatic disease discovered by uterine bleeding","volume":"37","author":"Gerber","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib101","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJM199712183372502","article-title":"Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease: Postmenopausal Estrogen\/Progestin Interventions Trial","volume":"337","author":"Langer","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(05)67063-8_bib102","doi-asserted-by":"crossref","first-page":"657","DOI":"10.5694\/j.1326-5377.2003.tb05400.x","article-title":"Screening for endometrial cancer","volume":"178","author":"Robertson","year":"2003","journal-title":"Med J Aust"},{"key":"10.1016\/S0140-6736(05)67063-8_bib103","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(05)78216-7","article-title":"Should tamoxifen users be screened for endometrial lesions?","volume":"351","author":"Neven","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(05)67063-8_bib104","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.AOG.0000154885.44002.ae","article-title":"Gynecologic cancer as a \u201csentinel cancer\u201d for women with hereditary nonpolyposis colorectal cancer syndrome","volume":"105","author":"Lu","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib105","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1470-2045(03)01224-5","article-title":"Laparoscopic prophylactic surgery for HNPCC gene mutation carrier: has the time come?","volume":"4","author":"Pocard","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib106","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1471-0528.1995.tb09066.x","article-title":"Histopathological findings in women with postmenopausal bleeding","volume":"102","author":"Gredmark","year":"1995","journal-title":"BJOG"},{"key":"10.1016\/S0140-6736(05)67063-8_bib107","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1006\/gyno.1995.1066","article-title":"Predicting endometrial cancer among older women who present with abnormal vaginal bleeding","volume":"56","author":"Feldman","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib108","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/1097-0142(20001015)89:8<1765::AID-CNCR17>3.0.CO;2-F","article-title":"The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta analysis","volume":"89","author":"Dijkhuizen","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib109","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1471-0528.2002.01088.x","article-title":"Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial cancer: a systematic quantitative review","volume":"109","author":"Clark","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/S0140-6736(05)67063-8_bib110","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1034\/j.1600-0412.2001.080009784.x","article-title":"Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial hyperplasia","volume":"80","author":"Clark","year":"2001","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/S0140-6736(05)67063-8_bib111","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0378-5122(03)00152-X","article-title":"Cost-effectiveness of the use of transvaginal sonography in the evaluation of postmenopausal bleeding","volume":"45","author":"Dijkhuizen","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/S0140-6736(05)67063-8_bib112","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.gco.0000136491.26463.c2","article-title":"Outpatient hysteroscopy and ultrasonography in the management of endometrial disease","volume":"16","author":"Clark","year":"2004","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib113","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1001\/jama.280.17.1510","article-title":"Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities","volume":"280","author":"Smith-Bindman","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(05)67063-8_bib114","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1034\/j.1600-0412.2001.810902.x","article-title":"Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis","volume":"81","author":"Gupta","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/S0140-6736(05)67063-8_bib115","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0029-7844(94)00421-9","article-title":"Combining vaginal ultrasonography and office endometrial sampling in the diagnosis of endometrial disease in postmenopausal women","volume":"85","author":"Van den Bosch","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib116","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/jama.288.13.1610","article-title":"Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review","volume":"288","author":"Clark","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(05)67063-8_bib117","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1471-0528.2003.02472.x","article-title":"Saline contrast hysterography in abnormal uterine bleeding: a systematic review and meta-analysis","volume":"110","author":"De Kroon","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/S0140-6736(05)67063-8_bib118","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/uog.203","article-title":"The pedicle artery sign based on sonography with color Doppler imaging can replace second-stage tests in women with abnormal vaginal bleeding","volume":"22","author":"Timmerman","year":"2003","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib119","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.OGX.0000120173.09136.4A","article-title":"Does hysteroscopy produce intraperitoneal spread of endometrial cancer cells?","volume":"59","author":"Revel","year":"2004","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/S0140-6736(05)67063-8_bib120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1525-1438.2000.010004275.x","article-title":"Impact of hysteroscopy on disease-free survival in clinically stage I endometrial cancer patients","volume":"10","author":"Obermair","year":"2000","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib121","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1067\/mob.2003.272","article-title":"Ultrasound assessment of endometrial thickness and endometrial polyps in women on hormonal replacement therapy","volume":"188","author":"Van den Bosch","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib122","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1159\/000327864","article-title":"Pap smears in women with endometrial carcinoma","volume":"45","author":"Gu","year":"2001","journal-title":"Acta Cytol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib123","first-page":"882","article-title":"Thin-layer cytology and histopathology in the evaluation of abnormal uterine bleeding","volume":"48","author":"Garcia","year":"2003","journal-title":"J Reprod Med"},{"key":"10.1016\/S0140-6736(05)67063-8_bib124","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1006\/gyno.1999.5694","article-title":"Clinical value of intraoperative gross examination in endometrial cancer","volume":"76","author":"Franchi","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib125","doi-asserted-by":"crossref","first-page":"639","DOI":"10.7863\/jum.2000.19.9.639","article-title":"High frequency transvaginal ultrasonography in preoperative assessment of myometrial invasion in endometrial cancer","volume":"19","author":"Arko","year":"2000","journal-title":"J Ultrasound Med"},{"issue":"suppl 1","key":"10.1016\/S0140-6736(05)67063-8_bib126","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1136\/ijgc-00009577-200303001-00088","article-title":"Pre-operative prediction of depth of myometrial invasion in patients with endometrial cancer: evaluation of ultrasound parmeters and development of a new logistic regression model","volume":"13","author":"Timmerman","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib127","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1148\/radiology.212.3.r99au29711","article-title":"Radiologic staging in patients with endometrial cancer: a meta-analysis","volume":"212","author":"Kinkel","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/S0140-6736(05)67063-8_bib128","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000010215","article-title":"Accuracy of intraoperative frozen-section diagnosis in stage I endometrial adenocarcinoma","volume":"49","author":"Kucera","year":"2000","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/S0140-6736(05)67063-8_bib129","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ygyno.2004.08.009","article-title":"Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer","volume":"95","author":"Horowitz","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib130","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1067\/mob.2000.106251","article-title":"Preoperative CA 125 in endometrial cancer: is it useful?","volume":"182","author":"Dotters","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib131","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer","volume":"60","author":"Creasman","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib132","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/1097-0142(19920101)69:1<200::AID-CNCR2820690132>3.0.CO;2-D","article-title":"The new International Federation of Gynecology and Obstetrics surgical staging and survival rates in early endometrial carcinoma","volume":"69","author":"Gal","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib133","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ssu.2980100107","article-title":"FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynaecological system: an analysis of 1973\u201387 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina","volume":"10","author":"Kosary","year":"1994","journal-title":"Semin Surg Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib134","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0360-3016(02)02913-9","article-title":"Is there a difference in outcome between stage I\u2013II endometrial cancer of papillary serous\/clear cell and endometrioid FIGO Grade 3 cancer?","volume":"54","author":"Alektiar","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S0140-6736(05)67063-8_bib135","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ygyno.2004.08.019","article-title":"Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium","volume":"95","author":"Creasman","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib136","first-page":"394","article-title":"The importance of peritoneal cytology in endometrial carcinoma","volume":"72","author":"Harouny","year":"1988","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib137","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ygyno.2004.06.042","article-title":"High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy","volume":"95","author":"Mariani","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib138","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1002\/1097-0142(19910615)67:12<3093::AID-CNCR2820671226>3.0.CO;2-L","article-title":"Endometrial adenocarcinoma in Norway: a study of a total population","volume":"67","author":"Abeler","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib139","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","article-title":"Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study","volume":"40","author":"Morrow","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib140","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0360-3016(92)90786-H","article-title":"Clinical stage I endometrial cancer: prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system","volume":"22","author":"Grigsby","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S0140-6736(05)67063-8_bib141","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1200\/JCO.2004.08.159","article-title":"Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial","volume":"22","author":"Creutzberg","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib142","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ygyno.2003.08.003","article-title":"Is there a prognostic difference between depth of myometrial invasion and the tumor-free distance from the uterine serosa in endometrial cancer?","volume":"91","author":"Lindauer","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib143","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/gyno.2002.6825","article-title":"Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer?","volume":"87","author":"Cohn","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib144","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.humpath.2004.02.007","article-title":"Prognostic parameters of endometrial carcinoma","volume":"35","author":"Prat","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib145","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1471-0528.2004.00335.x","article-title":"Total laparoscopic hysterectomy as a primary surgical treatment for endometrial cancer in morbidly obese women","volume":"112","author":"Yu","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/S0140-6736(05)67063-8_bib146","unstructured":"Lambrechts S, Van Gorp T, Amant F, et al. Laparoscopic assisted vaginal hysterectomy or abdominal hysterectomy in clinical FIGO stage I or IIa endometrial cancer. Int J Gynecol Cancer (in press)."},{"key":"10.1016\/S0140-6736(05)67063-8_bib147","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1006\/gyno.2000.6079","article-title":"High incidence of positive peritoneal cytology in low risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy","volume":"80","author":"Sonoda","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib148","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1006\/gyno.2001.6422","article-title":"High incidence of positive peritoneal cytology in low risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy","volume":"84","author":"Vergote","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib149","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.ygyno.2004.06.009","article-title":"Vaginal cuff recurrence of endometrial cancer treated by laparoscopic assisted vaginal hysterectomy","volume":"94","author":"Schneider","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib150","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1046\/j.1525-1438.1998.09817.x","article-title":"Anatomical and pathological study of retroperitoneal nodes in endometrial cancer","volume":"8","author":"Benedetti-Panici","year":"1998","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib151","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/gyno.1995.1005","article-title":"Adenocarcinoma of the endometrium survival comparisons of patients with and without pelvic node sampling","volume":"56","author":"Kilgore","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib152","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1200\/JCO.2005.04.144","article-title":"Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer","volume":"23","author":"Cragun","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib153","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1038\/sj.bjc.6600358","article-title":"Staging quality is related to the survival of women with endometrial cancer: a Scottish population based study","volume":"86","author":"Crawford","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib154","first-page":"825","article-title":"Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study","volume":"63","author":"Boronow","year":"1984","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib155","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1067\/mob.2000.107335","article-title":"Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?","volume":"182","author":"Mariani","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib156","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/gyno.1994.1038","article-title":"Surgical stage IV endometrial carcinoma: a study of 47 cases","volume":"52","author":"Goff","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib157","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/gyno.1997.4838","article-title":"The role of surgical cytoreduction in stage IV endometrial carcinoma","volume":"67","author":"Chi","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib158","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/gyno.2000.5843","article-title":"Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival","volume":"78","author":"Bristow","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib159","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ygyno.2003.10.031","article-title":"Uterine papillary serous carcinomas: the exigency for clinical trials","volume":"91","author":"Podratz","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib160","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ygyno.2003.08.027","article-title":"Uterine papillary serous carcinoma: comparisons of outcomes in surgical stage I patients with and without adjuvant therapy","volume":"91","author":"Huh","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib161","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/(SICI)1097-0142(19961015)78:8<1740::AID-CNCR14>3.0.CO;2-Y","article-title":"Clear cell carcinoma of the endometrium: prognosis and metastatic spread pattern","volume":"78","author":"Abeler","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib162","first-page":"212","article-title":"Papillary adenocarcinoma in the endometrium","volume":"70","author":"Ramirez-Gonzales","year":"1987","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib163","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/gyno.1999.5505","article-title":"Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma","volume":"74","author":"Cirisano","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib164","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1006\/gyno.1999.5513","article-title":"What staging surgery should be performed on patients with uterine papillary serous carcinoma?","volume":"74","author":"Geisler","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib165","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnci\/95.2.113","article-title":"Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant Chemo Therapy in Ovarian Neoplasm Trial","volume":"95","author":"Trimbos","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0140-6736(05)67063-8_bib166","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1006\/gyno.2000.6110","article-title":"The role of cytoreductive surgery in the management of sStage IV uterine papillary serous carcinoma","volume":"81","author":"Bristow","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib167","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1525-1438.2002.01149.x","article-title":"FIGO stage III and IV uterine papillary serous carcinoma: impact of residual disease on survival","volume":"12","author":"Memarzadeh","year":"2002","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib168","unstructured":"Despierre E, Moerman P, Vergote I, Amant F. Is there a role for neoadjuvant chemotherapy in the treatment of stage IV uterine papillary serous carcinoma? Int J Gynecol Cancer (in press)."},{"key":"10.1016\/S0140-6736(05)67063-8_bib169","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/02841860310014417","article-title":"A systematic overview of radiation therapy effects in uterine cancer (corpus uteri)","volume":"42","author":"Einhorn","year":"2003","journal-title":"Acta Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib170","first-page":"419","article-title":"Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib171","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(05)67063-8_bib172","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib173","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0167-8140(00)00171-7","article-title":"Post-operative high dose rate brachytherapy in patients with low to intermediate risk endometrial cancer","volume":"56","author":"Pearcey","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib174","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0090-8258(03)00126-4","article-title":"Survival after relapse in patients with endometrial cancer: results from a randomized trial","volume":"89","author":"Creutzberg","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib175","series-title":"GEC-ESTRO handbook of brachytherapy","first-page":"365","article-title":"Brachytherapy for endometrial cancer","author":"Poetter","year":"2002"},{"key":"10.1016\/S0140-6736(05)67063-8_bib176","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0090-8258(90)90166-I","article-title":"Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group Study","volume":"36","author":"Morrow","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib177","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/1097-0142(20010415)91:8<1437::AID-CNCR1150>3.0.CO;2-P","article-title":"Multimodality therapy for patients with clinical stage I and II malignant mixed M\u00fcllerian tumors of the uterus","volume":"91","author":"Manolitsas","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib178","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1006\/gyno.1993.1006","article-title":"A new aggressive approach to high-grade endometrial cancer of possible benefit to patients with stage I uterine papillary cancer","volume":"48","author":"Rosenberg","year":"1993","journal-title":"Gynecol Oncol"},{"issue":"suppl 16","key":"10.1016\/S0140-6736(05)67063-8_bib179","first-page":"455s","article-title":"Randomized phase III trial of whole pelvic radiotherapy vs cisplatin bases chemotherapy in patients with intermediate risk endometrial carcinoma","volume":"23","author":"Sagae","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib180","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/1097-0142(19890901)64:5<1011::AID-CNCR2820640507>3.0.CO;2-7","article-title":"A randomized trial of adjuvant progestagen in early endometrial cancer","volume":"64","author":"Vergote","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib181","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1200\/JCO.1996.14.2.357","article-title":"High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study","volume":"14","author":"Lentz","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib182","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ygyno.2003.09.018","article-title":"Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Whitney","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib183","first-page":"580","article-title":"Levonorgestrel-releasing intrauterine system (Mirena) as a therapy for endometrial hyperplasia and carcinoma","volume":"82","author":"Bahamondes","year":"2003","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/S0140-6736(05)67063-8_bib184","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0090-8258(84)90197-5","article-title":"Adriamycin and cis-diamminedichloroplatinum in the treatment of metastatic endometrial adenocarcinoma","volume":"19","author":"Seltzer","year":"1984","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib185","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0002-9378(84)90147-9","article-title":"Treatment of recurrent endometrial adenocarcinoma with a combination of doxorubicin and cisplatin","volume":"149","author":"Trop\u00e9","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib186","first-page":"539","article-title":"Treatment of advanced endometrial carcinoma with doxorubicin and cisplatin: effects on both untreated and previously treated patients","volume":"69","author":"Pasmantier","year":"1985","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/S0140-6736(05)67063-8_bib187","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/00000421-199312000-00007","article-title":"Circadian-timed combination doxorubicin-cisplatin chemotherapy for advanced endometrial carcinoma: a phase II study of the Gynecologic Oncology Group","volume":"16","author":"Barrett","year":"1993","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib188","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/jnci\/80.4.276","article-title":"Phase II evaluation of carboplatin in advanced endometrial carcinoma","volume":"80","author":"Long","year":"1988","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0140-6736(05)67063-8_bib189","first-page":"696","article-title":"Carboplatin therapy in advanced endometrial cancer","volume":"75","author":"Green","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib190","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1006\/gyno.1993.1310","article-title":"Treatment of advanced or recurrent endometrial carcinoma with single-agent carboplatin","volume":"51","author":"Burke","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib191","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/annonc\/mdg112","article-title":"Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definite results of a randomised study (55872) by the EORTC Gynaecological Cancer Group","volume":"14","author":"Aapro","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib192","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1200\/JCO.2004.02.088","article-title":"Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study","volume":"22","author":"Thigpen","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib193","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0090-8258(92)90224-7","article-title":"Uterine papillary serous carcinoma treated with cisplatin, doxorubicin, and cyclophosphamide","volume":"46","author":"Levenback","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib194","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1006\/gyno.1999.5444","article-title":"The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma","volume":"74","author":"Zanotti","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib195","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/gyno.2001.6211","article-title":"Treatment of uterine papillary serous carcinoma with paclitaxel","volume":"82","author":"Ramondetta","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib196","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.2004.07.184","article-title":"Phase III trial of doxorubicin plun cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group study","volume":"22","author":"Fleming","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib197","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1200\/JCO.2001.19.20.4048","article-title":"Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study","volume":"19","author":"Hoskins","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib198","first-page":"2","article-title":"Whole abdominal radiotherapy versus combination doxorubicin-cisplatin chemotherapy in advanced endometrial carcinoma: a randomized phase III trial of the Gynecologic Oncology Group","volume":"22","author":"Randall","year":"2003","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/S0140-6736(05)67063-8_bib199","first-page":"879","article-title":"Costs and benefits of routine follow-up after curative treatment for endometrial cancer","volume":"157","author":"Agboola","year":"1997","journal-title":"CMAJ"},{"key":"10.1016\/S0140-6736(05)67063-8_bib200","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0959-8049(01)00066-1","article-title":"Value and cost evaluation of routine follow up for patients with clinical stage I\/II endometrial cancer","volume":"37","author":"Morice","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/S0140-6736(05)67063-8_bib201","article-title":"A prospective randomized double-blind trial of estrogen replacement therapy vs placebo in women with stage I or II endometrial cancer: a Gynaecologic Oncology Group Study","volume":"78","author":"Barakat","year":"2004","journal-title":"Proceedings of the 35 Annual Meeting of the Society of Gynecologic Oncology"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673605670638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673605670638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T01:58:17Z","timestamp":1683165497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673605670638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":200,"journal-issue":{"issue":"9484","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0140673605670638"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(05)67063-8","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}